MELA Sciences was featured on Corporate Review in November 2014 to discuss the impacts skin cancer and benefits of early detection.
MelaFind is featured on News Channel 5 as they report on Cleveland Clinic’s use of the device to capture additional information about atypical moles
Personal stories. Melanoma survivors and doctors talk about the prevalence, warning signs, and what can be done to detect melanoma at its most curable stage
Light of 10 varying wavelengths shines from MelaFind® to acquire data from clinically atypical pigmented skin lesions.